Neuromuscular
Actively Recruiting Studies
Click edit button to add Call to Action URL!
If you think you may qualify for one of these studies, please contact Neurology Research at (303) 724-4644 or NeuroResearch@CUAnschutz.edu
| COMIRB # | Study Title | Principal Investigator | Eligibility and Information | IRB Approved Advertisement |
|---|---|---|---|---|
| Amyotrophic Lateral Sclerosis | ||||
| 19-1560 | Radicava/Edaravone Findings in Biomarkers From ALS (REFINE-ALS) | Laura Foster, MD | Clinical Trials | Trial Website |
| 19-2645 | Healey ALS Platform Trial | Laura Foster, MD | Clinical Trials | Platform Video |
| 20-0127 | Clinical Procedures To Support Research (CAPTURE ALS) | Laura Foster, MD | Clinical Trials | Trial Website |
| 20-2005 | MERIDIAN: A Study to Evaluate the Efficacy and Safety of Pegcetacoplan in Adults with ALS | Dianna Quan, MD | Clinical Trials | Trial Website |
| 20-2340 | A Phase 3b, Multicenter, Randomized, Double-Blind Study to Evaluate Efficacy and Safety of Oral Edaravone | Stacy Dixon, MD, PhD | Clinical Trials | N/A |
| 21-2598 | COURAGE-ALS: Phase 3, double-blind, randomized, placebo-controlled trial of reldesemtiv in patients aged 18 to 80 with ALS | Dianna Quan, MD | Clinical Trials | N/A |
Charcot Marie Tooth Disease | ||||
| 18-2537 | Natural History Evaluation of Charcot Marie Tooth Disease (CMT) Types CMT1B, CMT2A, CMT4A, CMT4C, and Others (INC-6601) | Vera Fridman, MD | Clinical Trials | N/A |
| 20-1525 | Genetics of CMT – Modifiers of CMT1A, New Causes of CMT (INC-6602) | Vera Fridman, MD | Clinical Trials | N/A |
Facioscapulohumeral Muscular Dystrophy | ||||
| 20-0405 | Motor Outcomes to Validate Evaluations in FSHD (MOVE FSHD) | Matthew Wicklund, MD | Clinical Trials | N/A |
| Inclusion Body Myositis | ||||
| 17-1132 | Using Next Generation Sequencing to Unravel the Pathogenesis of Sporadic Inclusion Body Myositis (IBM) – The International IBM Consortium Genetic Study | Matthew Wicklund, MD | Clinical Trials | N/A |
| Limb Girdle Muscular Dystrophy | ||||
| 19-2943 | Biomarker Development in LGMD 2i (MLB-01-001) | Matthew Wicklund, MD | Clinical Trials | N/A |
| 19-0506 | Defining Clinical Endpoints in Limb Girdle Muscular Dystrophy (LGMD) (GRASP) | Matthew Wicklund, MD | Clinical Trials | N/A |
| Myasthenia Gravis | ||||
| 20-0609 | A Study of TAK-079 in People with Generalized Myasthenia Gravis | Thomas Ragole, MD | Clinical Trials | N/A |
| 20-1787 | Myasthenia Gravis Inebilizumab Trial (MINT) | Dianna Quan, MD | Clinical Trials | N/A |
| 21-3289 | VIVACITY-MG: A Study of Nipocalimab Administered to Adults With Generalized Myasthenia Gravis | Dianna Quan, MD | Clinical Trials | N/A |
| TTR Amyloidosis | ||||
| 08-0623 | Transthyretin-Associated Amyloidoses Outcomes Survey (THAOS): A Global, Multi-Center, Longitudinal, Observational Survey of Patients with Documented Transthyretin (TTR) Mutations or Wild-Type TTR Amyloidosis | Dianna Quan, MD | Clinical Trials | N/A |